Finally, increased insulin granule size may contribute to metabolic disorders by impairing their membrane trafficking at the trans-Golgi network (TGN) [45, 46], which could be involved in BI-1-deficient β-cells. This evidence concerns the gene TMBIM6 and metabolic disease.